Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 13 of 14 found articles
 
 
  Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain
 
 
Title: Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain
Author: Balañá, C.
Vaz, M. A.
Lopez, D.
Peñas, R. de la
García-Bueno, J. M.
Molina-Garrido, M. J.
Sepúlveda, J. M.
Cano, J. M.
Bugés, C.
Sanz, S. M.
Arranz, J. L.
Perez-Segura, P.
Rodriguez, A.
Martin, J. M.
Benavides, M.
Gil, M.
Appeared in: Clinical and translational oncology
Paging: Volume 16 (2013) nr. 3 pages 273-279
Year: 2013
Contents:
Publisher: Springer Milan, Milan
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 13 of 14 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands